EGFR and tongue neoplasm: Furthermore, we demonstrated its utility in detecting and guiding resection of cervical SLNs using ICG, as well as primary tongue tumors and hypopharyngeal tumors using an EGFR-targeting nanobody conjugated to IRDye 800CW.